Skip to content
Misti logo — Next-generation lung delivery to protect every vulnerable ch...

Misti

Next-generation lung delivery to protect every vulnerable child and adult from infections

Australia Melbourne, Australia 12 employees Pre-Seed Total: $120.00K Biotechnology, Health Care

General Information

Company Name Misti
Location Australia Melbourne, Australia
Employees 12
Industries Biotechnology, Health Care
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Misti. To contact Misti, visit misti.com.au.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Misti compare?

A PDF of Misti and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Misti soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Misti

Misti

Slogan: Next-generation lung delivery to protect every child from infections

Description: Viral respiratory illnesses in children are frequent and costly, amounting to up to $50M AUD annually. The most common identified cause, Respiratory Syncytial Virus (RSV), has no proven therapeutics or vaccines. MISTI aims to offer a nebuliser that is a first-in-class, low-cost, scientifically validated lung delivery system to provide rapid protection.

Industries: Biotechnology, Health Care

Headquarter: Australia

Last Investment: $120.00K Pre Seed Round investment at 15 September 2023

Last Investment Investors: StartMate

As a Healthcare and Biotechnology company based in Australia, Misti is focused on developing a next-generation lung delivery system to combat viral respiratory illnesses in children, specifically targeting the common cause, Respiratory Syncytial Virus (RSV). The company recently secured a $120.00K pre-seed investment from StartMate on 15 September 2023. With the significant unmet need in the market for therapeutics and vaccines for RSV, Misti presents itself as a promising venture with the potential to make a substantial impact in the healthcare industry, both in terms of addressing a critical health issue and as an attractive investment opportunity.

Business keywords: Pediatric healthcare, Respiratory illnesses, Lung delivery system, Nebuliser technology, Respiratory Syncytial Virus (RSV), Therapeutics, Vaccines, Childhood infections

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round $120.00K 1
StartMate
15 Sep 2023

Misti Alternatives & Competitors

View All Alternatives
Misti vs

Pioneering needle-free mucosal vaccines for natural and robust immunity.

Venture round
Biotechnology, Health Care
Misti vs
Meissa Vaccines
Meissa Vaccines United States

Taming Viruses with ​Synthetic Biology

Series A
2 employees
Biotechnology, Health Care
Misti vs
RetroVirox Inc.
RetroVirox Inc. United States

The Virology CRO serving all your antiviral needs

Grant
4 employees
Biotechnology, Health Care

FAQ About Misti

Next-generation lung delivery to protect every vulnerable child and adult from infections
Misti is headquartered in Melbourne, Australia.
Misti operates in Biotechnology and Health Care. Its work centres on Pediatric healthcare, Respiratory illnesses, Lung delivery system and Nebuliser technology.
Misti has approximately 12 employees.
Misti has completed 1 funding round, raising a total of $120.00K. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Misti include Mucosis, Meissa Vaccines, RetroVirox Inc., Vaxart, Inc., BlueWillow Biologics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Misti and Mucosis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Misti, https://bouncewatch.com/company/misti, updated 14 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout